Kostyantyn Krysan
- Cancer Research top 5%
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects 19
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 12
- Cytokine Signaling Pathways and Interactions 8
- Immunology top 5%
- Immunotherapy and Immune Responses 9
- Immune cells in cancer 6
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 6
-
- Estrogen and related hormone effects 10
-
- Cancer, Stress, Anesthesia, and Immune Response 6
- Co-authors
- Steven M. DubinettSherven SharmaMariam DohadwalaKaren L. ReckampMehis PǒldHarnisha DalwadiYing LinJie Luo
- Cited by
- Cancer ResearchPharmacologyOncology
- Journals
- Nucleic Acids Research (1 paper)Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesUkraineUnited Kingdom
In The Last Decade
Kostyantyn Krysan
58 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 111
- Cancer Research 637
- Pharmacology 711
- Oncology 945
- Immunology 453
- Molecular Biology 1.1k
Countries citing papers authored by Kostyantyn Krysan
This map shows the geographic impact of Kostyantyn Krysan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kostyantyn Krysan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kostyantyn Krysan more than expected).
Fields of papers citing papers by Kostyantyn Krysan
This network shows the impact of papers produced by Kostyantyn Krysan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kostyantyn Krysan. The network helps show where Kostyantyn Krysan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kostyantyn Krysan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2021 | 64 | |
| 4 | 2021 | 15 | |
| 5 | 2020 | 76 | |
| 6 | 2019 | 2 | |
| 7 | 2019 | 57 | |
| 8 | 2018 | 11 | |
| 9 | 2016 | 2 | |
| 10 | 2016 | 3 | |
| 11 | 2016 | 1 | |
| 12 | 2014 | 36 | |
| 13 | 2014 | 4 | |
| 14 | 2013 | 31 | |
| 15 | 2008 | 41 | |
| 16 | 2008 | 46 | |
| 17 | 2006 | 68 | |
| 18 | 2004 | 49 | |
| 19 | 2004 | 74 | |
| 20 | 2002 | 216 |
About Kostyantyn Krysan
Kostyantyn Krysan is a scholar working on Oncology, Pharmacology and Cancer Research, having authored 60 papers that have together received 2.5k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (19 papers), Cancer Immunotherapy and Biomarkers (12 papers), Estrogen and related hormone effects (10 papers), Immunotherapy and Immune Responses (9 papers), Cytokine Signaling Pathways and Interactions (8 papers), Epigenetics and DNA Methylation (6 papers), Cancer, Stress, Anesthesia, and Immune Response (6 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Cancer Research (637 citations), Pharmacology (711 citations) and Oncology (945 citations). Kostyantyn Krysan has collaborated with scholars based in United States, Ukraine and United Kingdom. Frequent co-authors include Steven M. Dubinett, Sherven Sharma, Mariam Dohadwala, Karen L. Reckamp, Mehis Pǒld, Harnisha Dalwadi, Ying Lin, Jie Luo, Raj K. Batra and Nathalie Heuzé‐Vourc'h. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.